Anavex Life Sciences has completed clinical studies on blarcamesine, including Drug-Drug Interaction and ADME studies, in healthy volunteers. These studies support the drug's development for Alzheimer's disease and also benefit Rett syndrome and Fragile X syndrome programs. The FDA has cleared Anavex's IND application for Fragile X syndrome, and a meeting is scheduled to discuss adding pediatric patients to the Rett syndrome Phase 3 trial. These milestones position Anavex to progress its clinical programs through 2026.
Anavex Life Sciences' recent clinical milestones come as the health sector shows strong breadth on Pluang, with 133 of 150 US health stocks rising today. For readers following health stocks, here is Pluang's market snapshot as of Oct 21, 2026 02:12 WIB: SELLAS Life Sciences Group Inc. (SLS) rose 13.92% to USD 11.95 with a typical hold time of 3 days and balanced buy/sell activity, Relay Therapeutics Inc. (RLAY) increased 8.95% to USD 18.62 with an 11-day hold time, and Teladoc Health Inc. (TDOC) gained 8.55% to USD 6.22 despite 99% sell order activity and a 39-day hold time.
Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices ...
Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...
Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Collector Crypt, a Solana-based marketplace that tokenizes physical trading cards, has surpassed both Hyperliquid and Papertrade in 24-hour revenue, reaching over $532,550. This signals a shift in the crypto market towards tokenized collectibles rath...
